4//SEC Filing
Lieber Jonathan I 4
Accession 0000899243-18-026057
CIK 0001372299other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:00 PM ET
Size
25.9 KB
Accession
0000899243-18-026057
Insider Transaction Report
Form 4
HISTOGENICS CORPHSGX
Lieber Jonathan I
Chief Financial Officer
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2018-10-01−28,000→ 0 totalExercise: $2.56Exp: 2026-02-25→ Common Stock (28,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2018-10-01−50,000→ 0 totalExercise: $1.72Exp: 2027-02-13→ Common Stock (50,000 underlying) - Award
Employee Stock Option (Right to Buy)
2018-10-01+50,000→ 50,000 totalExercise: $0.57Exp: 2027-02-13→ Common Stock (50,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2018-10-01−130,000→ 0 totalExercise: $2.63Exp: 2028-02-15→ Common Stock (130,000 underlying) - Award
Employee Stock Option (Right to Buy)
2018-10-01+130,000→ 130,000 totalExercise: $0.57Exp: 2028-02-15→ Common Stock (130,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2018-10-01−30,000→ 0 totalExercise: $6.37Exp: 2025-07-01→ Common Stock (30,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2018-10-01−110,000→ 0 totalExercise: $6.37Exp: 2025-07-01→ Common Stock (110,000 underlying) - Award
Employee Stock Option (Right to Buy)
2018-10-01+110,000→ 110,000 totalExercise: $0.57Exp: 2015-07-01→ Common Stock (110,000 underlying) - Award
Employee Stock Option (Right to Buy)
2018-10-01+28,000→ 28,000 totalExercise: $0.57Exp: 2026-02-25→ Common Stock (28,000 underlying)
Footnotes (7)
- [F1]The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each "Relevant Option" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options.
- [F2]The stock option was originally granted to the Reporting Person on July 2, 2015. This option vests over four (4) years of service following July 2, 2015, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and in thirty-six (36) equal monthly installments thereafter.
- [F3]The stock option was originally granted to the Reporting Person on February 26, 2016. This option vests over four (4) years of service to the Issuer following February 26, 2016, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter.
- [F4]The stock option was originally granted to the Reporting Person on February 14, 2017, This option vests over four (4) years of service to the Issuer following February 14, 2017, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter.
- [F5]The stock option was originally granted to the Reporting Person on February 16, 2018. This option vests over four (4) years of service to the Issuer following February 16, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter.
- [F6]This transaction reflects the cancellation for no consideration of certain outstanding stock options to purchase common stock of the Issuer that were previously granted to the Reporting Person (the "Cancelled Options").
- [F7]The Cancelled Option was originally granted to the Reporting Person on July 2, 2015 and was to vest in full if the Issuer's Common Stock price reached $19.92 per shares or above for any consecutive sixty (60) day period within four (4) years of the date of grant.
Documents
Issuer
HISTOGENICS CORP
CIK 0001372299
Entity typeother
Related Parties
1- filerCIK 0001350090
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 5:00 PM ET
- Size
- 25.9 KB